Traidl, Stephan, Klug, Ilona, Rodriguez, Elke, Harder, Inken, Lieb, Wolfgang, Weidinger, Stephan, Schulz, Thomas F., Sodeik, Beate, Döhner, Katinka, Roesner, Lennart M.; Werfel, Thomas. Journal of Allergy [...] Buchholz, Frank, Grundhoff, Adam, Schambach, Axel, Thirion, Christian, Mittrücker, Hans-Willi, Schulze zur Wiesch, Julian, Hauber, Joachim; Chemnitz, Jan. PLOS ONE. 2024. Publisher's page Transient s [...] Buchegger, Theresa, Kühnel, Mark Philipp, Blank, Patrick, Philipp, Friederike, Oleaga-Quintas, Carmen, Schulz, Ansgar, Grimley, Michael, Goethe, Ralph, Jonigk, Danny, Kalinke, Ulrich, Boisson-Dupuis, Stéphanie

22;2019:4508048. doi: 10.1155/2019/4508048. PMID: 31428635 Müller-Deile J, Schenk H, Schroder P, Schulze K, Bolaños-Palmieri P, Siegerist F, Endlich N, Haller H, Schiffer M. Circulating factors cause p

ng the Mode of Action of a novel broadly acting antiviral inhibitor Supervisor: Prof. Dr. Thomas Schulz, Institute of Virology, MHH Academic Background: Oncology, Sichuan University, China Lena Wolpert

difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test . R. Minso, A. Schulz, C. Dopfer, N. Alfeis, A. van Barneveld, L. Makartian-Gyulumyan, G. Hansen, S. Junge, C. Müller,

difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test. R. Minso, A. Schulz, C. Dopfer, N. Alfeis, A. van Barneveld, L. Makartian-Gyulumyan, G. Hansen, S. Junge, C. Müller,

Cluster of Excellence are dedicated to COVID-19 / SARS-CoV-2. Projekt leaders are: Prof. Dr. Thomas F. Schulz, Prof. Dr. Gisa Gerold, Prof. Dr. Thomas Pietschmann, Prof. Dr. Gerard Krause, Prof. Dr. Jens Bosse

S2352-3964(20)30260-7 Scholz KH, Lengenfelder B, Thilo C, Jeron A, Stefanow S, Janssens U, Bauersachs J, Schulze PC, Winter KD, Schroder J, Vom Dahl J, von Beckerath N, Seidl K, Friede T, Meyer T. Impact of COVID-19 [...] Re-purposing with a purpose. J Mol Cell Cardiol 2020;146:41-42 DOI: S0022-2828(20)30227-3 Jendrny P, Schulz C, Twele F, Meller S, von Kockritz-Blickwede M, Osterhaus ADME, Ebbers J, Pilchova V, Pink I, Welte [...] Domenico E, Wendisch D, Grasshoff M, Kapellos TS, Beckstette M, Pecht T, Saglam A, Dietrich O, Mei HE, Schulz AR, Conrad C, Kunkel D, Vafadarnejad E, Xu CJ, Horne A, Herbert M, Drews A, Thibeault C, Pfeiffer

Kapanadze Dr. med. Christian Beger Dr. med. Khaled Dastagir Nicole Schroth Yuangao Xu Theresa Karg Carla Schulze Technical Assistants Stefan Sablotny Scientific profile In the laboratory, we are investigating the

PMCID: PMC11915863. Riemann L, Gutierrez R, Odak I, Barros-Martins J, Roesner LM, Leon Lara X, Falk C, Schulz TF, Hansen G, Werfel T, Förster R; RESIST SI Cohort Investigators. Integrative deep immune profiling [...] S, Jiang X, Riemann L, Traidl S, Lange B, Sühs KW, Illig T, Strowig T, Li Y, Förster R, Huehn J, Schulz TF, Werfel T; RESIST SI Cohort Investigators. The RESIST Senior Individuals Cohort: Design, participant [...] PMC8381713. Bošnjak B, Odak I, Ritter C, Stahl K, Graalmann T, Steinbrück L, Blasczyk R, Falk CS, Schulz TF, Wedemeyer HH, Cornberg M, Ganser A, Förster R, Koenecke C. Case Report: Convalescent Plasma Therapy

human neutralizing monoclonal antibodies against SARS-CoV-2 Project leader: Prof. Dr. med. Thomas F. Schulz Department / Institute: Institute of Virology We want to generate broadly neutralizing, i.e. protective